# Sigachi Industries (NSE: SIGACHI) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SIGACHI · Pivot · prices to 22 Oct 2026

Sigachi Industries (NSE: SIGACHI) closed at ₹26.24 on 22 Oct 2026, down 0.08% on the day. With a market capitalisation of ₹1,003 Cr, it ranks 1450th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was 11.6% in FY25. Over the past year the share price has fallen 30.3%. Its 52-week range is ₹16.65 (30 Mar 2026) to ₹40.80 (1 Dec 2025); the last close is 35.7% below the high. Promoters held 36.69% of the company as of 30 Jun 2026; 20.04% of promoter shares were pledged.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹26.24 |
| Market cap | ₹1,003 Cr |
| ROE | 11.6% (FY25) |
| ROCE | 15.8% (FY25) |
| Debt to equity | 0.2 |
| 52-week high | ₹40.80 (1 Dec 2025) |
| 52-week low | ₹16.65 (30 Mar 2026) |
| 1-year return | −30.3% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹488 Cr | ₹70 Cr |
| FY24 | ₹399 Cr | ₹57 Cr |
| FY23 | ₹302 Cr | ₹44 Cr |
| FY22 | ₹250 Cr | ₹40 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 36.69%
- Foreign institutions: 1.25%
- Domestic institutions: 0.00%
- Non-institutions: 62.05%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [GPT Healthcare](https://app.pivotnow.in/stock/GPTHEALTH) | ₹135.22 | ₹1,110 Cr | 26.3 | — |
| [Bajaj Healthcare](https://app.pivotnow.in/stock/BAJAJHCARE) | ₹327.65 | ₹1,103 Cr | 48.6 | — |
| [Bafna Pharmaceuticals](https://app.pivotnow.in/stock/BAFNAPH) | ₹451.95 | ₹1,069 Cr | 96.4 | — |
| [Lincoln Pharmaceuticals](https://app.pivotnow.in/stock/LINCOLN) | ₹517.50 | ₹1,037 Cr | 11.8 | — |
| [Laxmi Dental](https://app.pivotnow.in/stock/LAXMIDENTL) | ₹177.55 | ₹976 Cr | 33.7 | — |
| [Themis Medicare](https://app.pivotnow.in/stock/THEMISMED) | ₹98.08 | ₹903 Cr | — | — |

## Questions and answers

### What is the share price of Sigachi Industries today?

Sigachi Industries (NSE: SIGACHI) last closed at ₹26.24 on 22 Oct 2026. Its 52-week high is ₹40.80 and its 52-week low is ₹16.65.

### What is the market cap of Sigachi Industries?

Sigachi Industries' market capitalisation is ₹1,003 Cr (₹1,003 Cr) at the 22 Oct 2026 close, ranking 1450th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Sigachi Industries?

Return on equity was 11.6% in FY25 and return on capital employed was 15.8% in FY25 (consolidated figures).

### Is Sigachi Industries a debt-free company?

No. Sigachi Industries' debt-to-equity ratio was 0.2 in FY25, with total debt of ₹0 Cr.

### How has Sigachi Industries stock performed over the last year?

Sigachi Industries' share price has fallen 30.3% over the past year, −1.2% over three months and −15.6% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Sigachi Industries?

As of 30 Jun 2026: promoters 36.69%, foreign institutions 1.25%, domestic institutions 0.00%, non-institutions 62.05%. 20.04% of promoter shares were pledged.

### Who are Sigachi Industries' competitors?

The listed Pharma & Healthcare companies closest to Sigachi Industries by market cap are GPT Healthcare, Bajaj Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals, Laxmi Dental and Themis Medicare.

### Is Sigachi Industries a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Sigachi Industries' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SIGACHI against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.